Constructive UK data
June 20, 2026
12 min
Full
297 of 364
June 20, 2026
Constructive UK data
0:00 / 12:27
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Dr John Campbell Episodes Around June 20, 2026
Episode 297 of 364 — walk the feed in the order it was published.
12:27This episodeConstructive UK data
Summary
Less people going to hospital with Omicron infection compared to Delta infection. Apologies, I had a few technical problems with todays video
Zoe update: Wednesday 22 December 2021
https://www.youtube.com/watch?v=CIGC310hPoI
https://covid.joinzoe.com/post/everything-we-know-so-far-about-omicron
https://joinzoe.com/learn/category/covid
https://joinzoe.com/learn/new-omicron-variant
144,284 new daily symptomatic cases of COVID in the UK
In people who have had at least 2 vaccine doses
56,346 new daily symptomatic cases in the UK
70% + cases in England are now Omicron
The UK R value, 1.2
R value in London is 1.5.
From 17,000 omicron cases
Runny nose
Headache
Fatigue (either mild or severe)
Sneezing
Sore throat
(NHS test and trace is not telling users of their Omicron status anymore)
Report 50 - Hospitalisation risk for Omicron cases in England
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-50-severity-omicron/
https://www.theguardian.com/world/2021/dec/22/risk-of-hospital-stay-40-lower-with-omicron-than-delta-uk-data-suggests
Differences in the risk of hospitalisation between Omicron and Delta
1st to 14th December inclusive
Analysed data from all PCR-confirmed SARS-CoV-2 cases in England
Cases
S-gene Target Failure (SGTF) and genetic data
Omicron, n = 56,000
Delta, n = 269,000
Reduction in the risk of hospitalisation for Omicron relative to Delta infections
Endpoint, any attendance at hospital
20-25% reduced risk
Endpoint, hospitalisation lasting 1 day or longer
40-45% reduced risk
These reductions must be balanced against the larger risk of infection with Omicron,
due to the reduction in protection provided by both vaccination and natural infection.
Intrinsic differences in severity between Omicron and Delta
Omicron may result in slightly less severe disease
From the few neither previously infected nor vaccinated,
risk of hospitalisation, 11% lower for Omicron versus Delta
Level of protection from previous infection
Reduces the risk of any hospitalisation by 50%
Reduces the risk of a hospital stay of 1+ days by 61%
Risk of symptomatic infection with omicron
More protection after PF/MD than AZ
Hospitalisation risk by vaccination state